Terminated PHASE4 INTERVENTIONAL 2-arm NCT05554679

Maternal and Fetal Outcome With Metformin Therapy for Obese Pregnant Women .

Maternal and Fetal Outcome With Metformin Therapy for Obese Pregnant Women a Randomized Control Trial.

Sponsor: Assiut University

Conditions Metformin for Obese Pregnant Women

Interventions Metformin

Updated 6 times since 2022 Last updated: Feb 10, 2024 Started: Feb 1, 2021 Primary completion: Dec 30, 2022 Completion: Jul 11, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

financial issues

Other terminated trials from Assiut University

See all terminations from Assiut University

Listed as NCT05554679, this PHASE4 trial focuses on Metformin for Obese Pregnant Women and remains terminated or withdrawn. Sponsored by Assiut University, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Mar 2024 — Jul 2024 [monthly]

Terminated PHASE4

Status: Recruiting → Terminated
Jan 2023 — Mar 2024 [monthly]

Recruiting PHASE4
Nov 2022 — Jan 2023 [monthly]

Recruiting PHASE4

▶ Show 1 earlier version

Sep 2022 — Nov 2022 [monthly]

Recruiting PHASE4

First recorded

Feb 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt